Spero Therapeutics Inc (SPRO)

May 21, 2026

Spero Therapeutics (SPRO) Q1 2026 Earnings: Why the Beat MattersCEO Earnings Statement - Newser

May 21, 2026

May 21, 2026

SPRO Technical Analysis | Trend, Signals & Chart Patterns | SPERO THERAPEUTICS INC (NASDAQ:SPRO) - ChartMill

May 21, 2026

May 17, 2026

Spero Therapeutics, Inc. Common Stock (SPRO) Stock Price Today & Analysis - Gotrade

May 17, 2026

May 13, 2026

Is Spero Therapeutics (SPRO) 110.3% Overvalued After Q1 2026 Ear - GuruFocus

May 13, 2026

May 13, 2026

Spero Therapeutics 1Q Loss $7.2M >SPRO - Moomoo

May 13, 2026

May 13, 2026

Spero Therapeutics Q1 revenue drops on decreased clinical activity - TradingView

May 13, 2026

May 13, 2026

Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update - The Manila Times

May 13, 2026

May 13, 2026

Spero Therapeutics (NASDAQ: SPRO) leans on GSK-partnered tebipenem ahead June 2026 FDA date - Stock Titan

May 13, 2026

May 13, 2026

Spero Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 13, 2026

May 13, 2026

Spero Therapeutics (SPRO) trims Q1 2026 loss ahead key tebipenem FDA date - Stock Titan

May 13, 2026

May 13, 2026

FDA to rule June 18 on Spero oral antibiotic for severe UTIs - Stock Titan

May 13, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 10, 2026

MSN Money - MSN

May 10, 2026

May 09, 2026

Number of shareholders of Spero Therapeutics, Inc. – NASDAQ:SPRO - TradingView

May 09, 2026

May 08, 2026

SPRO SEC FilingsSpero Therapeuti 10-K, 10-Q, 8-K Forms - Stock Titan

May 08, 2026

May 07, 2026

SPRO FINAL DEADLINE TODAY: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important July 25 Deadline in Securities Class ActionSPRO - TMX Newsfile

May 07, 2026

May 07, 2026

Spero Therapeutics (SPRO.US) will release its earnings report after the market closes on May 13. - 富途牛牛

May 07, 2026

May 06, 2026

Spero Therapeutics (SPRO) officer sells shares for RSU tax obligations - Stock Titan

May 06, 2026

May 06, 2026

Spero Therapeutics CEO sells $63,352 in company stock By Investing.com - Investing.com Australia

May 06, 2026

May 06, 2026

Spero Therapeutics CEO sells $63,352 in company stock - Investing.com India

May 06, 2026

May 05, 2026

SPRO: The fleeting Sparrow - Moomoo

May 05, 2026

May 05, 2026

No call planned as Spero sets May 13 for Q1 results update - Stock Titan

May 05, 2026

May 05, 2026

Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 - GlobeNewswire

May 05, 2026

May 01, 2026

SPRO Stock Price, Quote & Chart | SPERO THERAPEUTICS INC (NASDAQ:SPRO) - ChartMill

May 01, 2026

Apr 30, 2026

Spero Therapeutics, Inc. (NASDAQ:SPRO) Sees Significant Growth in Short Interest - MarketBeat

Apr 30, 2026

Apr 27, 2026

Best Momentum Stock to Buy for October 10th - MSN

Apr 27, 2026

Apr 27, 2026

Spero Therapeutics (NASDAQ: SPRO) 2026 proxy adds stock increase and new incentive plan - Stock Titan

Apr 27, 2026

Apr 27, 2026

Spero Therapeutics (SPRO) price target decreased by 20.00% to 4.08 - MSN

Apr 27, 2026

Apr 27, 2026

[ARS] Spero Therapeutics, Inc. SEC Filing - Stock Titan

Apr 27, 2026

Apr 25, 2026

ROSEN, Top Ranked Investor Counsel, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class ActionSPRO - TMX Newsfile

Apr 25, 2026

Apr 20, 2026

Spero Therapeutics (SPRO) Stock Volume Spike Alert (Builds on Momentum) 2026-04-20Open Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Apr 18, 2026

Spero Therapeutics (SPRO) Stock Insider Buying (Market Focus) 2026-04-18Algo Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 18, 2026

Apr 17, 2026

SPRO Forecast, Price Target & Analyst Ratings | SPERO THERAPEUTICS INC (NASDAQ:SPRO) - ChartMill

Apr 17, 2026

Apr 16, 2026

Spero Therapeutics Stock Rises Above 50-Day Moving Average - National Today

Apr 16, 2026

Apr 16, 2026

Spero Therapeutics (NASDAQ:SPRO) Share Price Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat

Apr 16, 2026

Apr 13, 2026

Spero Therapeutics (NASDAQ: SPRO) asks shareholders to double authorized shares to 240M - Stock Titan

Apr 13, 2026

Apr 11, 2026

Portfolio Shifts: Is Spero Therapeutics Inc stock showing strong momentum2026 Rallies & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

MACD Signal: Does Spero Therapeutics Inc have pricing power2026 Growth vs Value & Verified Swing Trading Watchlist - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Can Spero Therapeutics (SPRO) Stock increase dividends | Price at $2.63, Down 5.40%Hot Community Stocks - Newser

Apr 10, 2026

Apr 09, 2026

Non Tuberculous Mycobacterial Infections Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, AN2 Therapeutics, Mannkind Corp., Spero Therapeutics, Savara Pharmaceuticals - Barchart.com

Apr 09, 2026

Apr 09, 2026

Is Spero Therapeutics (SPRO) Stock undervalued by the market | Price at $2.73, Up 0.55%Crowd Breakout Signals - Newser

Apr 09, 2026

Apr 08, 2026

Market Overview: Will Spero Therapeutics Inc benefit from seasonality2026 Pullbacks & Capital Efficiency Focused Ideas - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Market Review: What is the PEG ratio of Spero Therapeutics IncInflation Watch & Safe Capital Growth Stock Tips - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Is Spero Therapeutics (SPRO) Stock Reacting to Market | Price at $2.73, Up 2.43%Institutional Flow - Newser

Apr 08, 2026

Apr 07, 2026

Spero Therapeutics Stock Rises Above 50-Day Average - National Today

Apr 07, 2026